Related Experiment Videos
Myocardial viability: what do we need?
H Schoeder1, M Friedrich, H Topp
1Department of Radiology and Nuclear Medicine, Urban Hospital Berlin, Germany.
Insights
Detecting viable myocardium is crucial for select coronary heart disease (CHD) patients before revascularization. Thallium-201 myocardial scintigraphy is the preferred method for identifying this viable heart tissue.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Coronary revascularization decisions for chronic coronary heart disease (CHD) and acute myocardial infarction (AMI) depend on anatomy, ventricular function, comorbidities, and age.
- Pre-procedural assessment requires confirmation of significant ischemia.
- Identifying viable myocardium is critical in specific patient subsets where standard parameters are inconclusive.
Purpose of the Study:
- To evaluate methods for detecting viable myocardium in patients with CHD.
- To determine the most effective imaging modality for guiding revascularization decisions in select cases.
- To compare Thallium-201 scintigraphy with alternative imaging techniques.
Main Methods:
- Review and comparison of diagnostic imaging techniques for myocardial viability.
- Focus on Thallium-201 myocardial scintigraphy (rest-redistribution with re-injection).
- Discussion of Positron Emission Tomography (PET) and Technetium-99m sestamibi SPECT.
Main Results:
- A significant amount of ischemic but viable myocardium is essential for successful revascularization.
- Thallium-201 myocardial scintigraphy is an established, proven, and cost-effective method for detecting myocardial viability.
- Alternative methods like PET and Tc-99m sestamibi SPECT are discussed but Thallium-201 remains central.
Conclusions:
- Myocardial viability assessment is important for a small subset of CHD patients, particularly those with hibernating myocardium.
- Thallium-201 myocardial scintigraphy is the method of choice for detecting ischemic but viable myocardium.
- This technique aids in optimizing revascularization strategies for select patients with coronary heart disease.
Abstract:
Coronary revascularization in patients with chronic coronary heart disease (CHD) or acute myocardial infarction (AMI) is mainly based on factors such as coronary anatomy, ventricular function, accompanying diseases and the patient's biological age. Rest- or exercise-induced ischaemia should be proven before a bypass operation or percutaneous transluminal coronary angioplasty. Although a significant amount of ischaemic but still viable myocardium is a necessary condition for successful revascularization, the detection of viable myocardium is of major importance in a rather small subset of patients. These are patients with hibernating (or a combination of hibernating and stunned) myocardium in whom the aforementioned parameters do not yield an unequivocal result. Thallium-201 myocardial scintigraphy with re-injection or rest-redistribution is an established, proven and cost-effective way of detecting viable myocardium. Other methods such as positron emission tomography with different tracers or technetium-99m sestamibi SPET are discussed and compared to thallium-201 SPET. In conclusion, the detection of ischaemic but still viable myocardium is of importance in only a rather small subset of patients with CHD. In this context thallium-201 myocardial SPET is and still remains the method of choice.